NutriSystem’s (NTRI) Buy Rating Reaffirmed at DA Davidson

DA Davidson reiterated their buy rating on shares of NutriSystem (NASDAQ:NTRI) in a report released on Friday. The brokerage currently has a $80.00 price objective on the stock. DA Davidson also issued estimates for NutriSystem’s Q1 2018 earnings at $0.25 EPS, Q2 2018 earnings at $0.94 EPS, Q3 2018 earnings at $0.58 EPS and Q4 2018 earnings at $0.54 EPS.

NTRI has been the subject of a number of other reports. B. Riley set a $74.00 target price on shares of NutriSystem and gave the company a buy rating in a research note on Thursday, October 26th. Zacks Investment Research lowered shares of NutriSystem from a buy rating to a hold rating in a research note on Friday, December 15th. BidaskClub lowered shares of NutriSystem from a buy rating to a hold rating in a research note on Saturday, August 26th. Finally, Lake Street Capital set a $73.00 target price on shares of NutriSystem and gave the company a buy rating in a research note on Thursday, October 26th. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock currently has a consensus rating of Buy and an average target price of $67.56.

NutriSystem (NASDAQ:NTRI) opened at $54.35 on Friday. The stock has a market capitalization of $1,630.00, a P/E ratio of 29.38, a P/E/G ratio of 1.51 and a beta of 1.01. NutriSystem has a 12-month low of $31.60 and a 12-month high of $67.95.

NutriSystem (NASDAQ:NTRI) last announced its earnings results on Wednesday, October 25th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.03. The business had revenue of $158.10 million during the quarter, compared to analyst estimates of $155.21 million. NutriSystem had a net margin of 8.27% and a return on equity of 49.69%. The company’s quarterly revenue was up 26.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.27 EPS. equities analysts predict that NutriSystem will post 1.95 EPS for the current year.

NutriSystem announced that its board has approved a stock repurchase program on Wednesday, October 25th that authorizes the company to repurchase $50.00 million in shares. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.

In other news, Director Jay Herratti sold 3,799 shares of the company’s stock in a transaction on Thursday, October 12th. The stock was sold at an average price of $60.00, for a total value of $227,940.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Michael P. Monahan sold 11,335 shares of the stock in a transaction on Wednesday, September 27th. The stock was sold at an average price of $55.03, for a total value of $623,765.05. Following the completion of the sale, the chief financial officer now owns 55,933 shares of the company’s stock, valued at approximately $3,077,992.99. The disclosure for this sale can be found here. Insiders sold a total of 36,134 shares of company stock valued at $1,913,045 over the last 90 days. 2.40% of the stock is currently owned by company insiders.

A number of hedge funds have recently modified their holdings of NTRI. Aperio Group LLC increased its stake in NutriSystem by 8.8% in the 2nd quarter. Aperio Group LLC now owns 9,701 shares of the company’s stock worth $505,000 after buying an additional 781 shares in the last quarter. SG Americas Securities LLC purchased a new stake in NutriSystem in the 2nd quarter worth $199,000. Bank of New York Mellon Corp boosted its holdings in shares of NutriSystem by 2.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 508,051 shares of the company’s stock valued at $26,445,000 after purchasing an additional 11,553 shares during the last quarter. Legal & General Group Plc boosted its holdings in shares of NutriSystem by 10.0% during the 2nd quarter. Legal & General Group Plc now owns 54,432 shares of the company’s stock valued at $2,833,000 after purchasing an additional 4,944 shares during the last quarter. Finally, BNP Paribas Arbitrage SA boosted its holdings in shares of NutriSystem by 97.3% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 11,823 shares of the company’s stock valued at $615,000 after purchasing an additional 5,832 shares during the last quarter. Institutional investors and hedge funds own 92.48% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This report was published by Community Financial News and is owned by of Community Financial News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.com-unik.info/2017/12/26/nutrisystems-ntri-buy-rating-reaffirmed-at-da-davidson.html.

About NutriSystem

Nutrisystem, Inc is a provider of weight management products and services, including nutritionally balanced weight loss programs, multi-day kits available at retail locations and digital tools to support weight loss. The Company’s program customers purchase monthly food packages containing four-week meal plan consisting supply of breakfasts, lunches, dinners and snacks and flex meal plan recipes, which they supplement with fresh fruits, vegetables and dairy.

Analyst Recommendations for NutriSystem (NASDAQ:NTRI)

Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit